Friday, September 29, 2023


Biotechnology News Magazine

seqWell launches plexWell™ – a Single-cell Rapid Kit for streamlined scRNA Sequencing

Latest Posts

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Airway Therapeutics began recruiting patients on March 28, 2023, for daily treatment up to 7 days at the highest dose of zelpultide alfa (rhSP-D) following a Data Safety Monitoring Committee (DSMC) report of no safety concerns.

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care

At the global HIMSS1 Conference, Roche showcases navify Algorithm Suite, a single platform offering clinicians access to medical algorithms generating insights to help improve care decisions.

PathO3Gen Solutions UVZone® Proven 99.9993% Effective Against Candida Auris: Shoes and Floors in Healthcare Facilities Should Be Addressed as Outbreak Continues

PathO3Gen Solutions’ multi-patented UVZone Shoe Sanitizing Stations, when placed in high-traffic and high-risk areas, enhance healthcare facility infection control measures, and may improve overall hospital biosafety.

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Under the terms of Pharming's 2019 exclusive license agreement with Novartis for leniolisib, the corresponding first commercial sale of Joenja® triggers a $10 million milestone payment by Pharming to Novartis.

February 5, 2021

seqWell announced the release of its plexWell Single Cell Rapid Kit, simplifying and accelerating the preparation of NGS libraries for single-cell RNA sequencing.

plexWell Single Cell Rapid is the first in a series of products in the single-cell analysis area and offers a comprehensive library prep solution employing technology that enables increased control, while minimizing bias and variation compared to other methods.

seqWell notes the kit introduces novel improvements to the Smart-seq2 method by combining cDNA synthesis and amplification, and reducing the QC and normalization burden by 75%, to achieve a single-day library prep workflow. This simplified approach can produce sequencing-ready, full-length transcriptome libraries from hundreds to thousands of sorted cells at a time. Unique features of plexWell technology, such as iterative barcoding and auto-normalization, create balanced library pools without the need for further sample or library normalization. The method has been optimized for low cDNA inputs to maintain library complexity, improve detection of low-abundance targets, and preserve variant and isoform information.

“We have tested the plexWell Rapid Kit on human peripheral blood mononuclear cells (PBMCs), notoriously challenging for having a very low RNA content,” said Simone Picelli, Team Leader, Single-Cell Genomics Platform at Institute Ophthalmology Basel (IOB). “We were impressed by the sequencing QC metrics: very high number of detected genes, low number of ribosomal and mitochondrial reads, all with a very high percentage of reads uniquely mapping to exons.”

“We used the scRapid kit on different samples such as cell lines, human retinal organoids and peripheral blood mononuclear cells (PBMCs),” Dr. Picelli continued. “The kit works well regardless of the source material, but it really shines when using it in challenging cells containing very little RNA such as the PBMCs.”

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine